California · 2025–26 Regular Session · Assembly Bill
AB 968: Contraceptives.
Passed one chamber Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
AB 968 is a assembly bill introduced in the California Assembly on February 20, 2025. According to its official title, it concerns: Contraceptives. Primary sponsor: Tasha Boerner (D). Most recent recorded action (September 13, 2025): Ordered to inactive file at the request of Senator Pérez.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Legislative Counsel’s Digest (official, as of the latest version). Written by nonpartisan legislative staff; reproduced verbatim.
Existing law, the Pharmacy Law, establishes, in the Department of Consumer Affairs, the California State Board of Pharmacy to license and regulate the practice of pharmacy.
Existing law authorizes a physician and surgeon, nurse practitioner, registered nurse, and specified other health care practitioners acting within the scope of their practice to use a self-screening tool to identify patient risk factors for the use of self-administered hormonal contraceptives by a patient and, after examination, to prescribe, furnish, or dispense self-administered hormonal contraceptives to the patient.
This bill would, instead, make those provisions applicable to contraceptives.
Existing law authorizes a pharmacist to furnish self-administered hormonal contraceptives in accordance with standardized procedures or protocols developed and approved by both the California State Board of Pharmacy and the Medical Board of California, in consultation with specified other entities.
This bill would authorize a pharmacist to also furnish federal Food and Drug Administration-approved nonhormonal contraceptives in accordance with those standardized procedures or protocols. The bill would require a pharmacist, for each federal Food and Drug Administration-approved nonhormonal contraceptives initiated, to provide the recipient with a standardized fact sheet, as specified.
Existing law prohibits a pharmacist, pharmacist’s employer, or pharmacist’s agent from directly charging a patient a separate consultation fee for emergency contraception drug therapy services and requires the pharmacist to disclose the total retail price of the emergency contraception drug therapy. Existing law makes those provisions inoperative for dedicated emergency contraception drugs if these drugs are reclassified as over-the-counter products by the federal Food and Drug Administration.
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Tasha Boerner | Primary sponsor | Democratic | Assembly | 77 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Ordered to inactive file at the request of Senator Pérez.
- Read second time. Ordered to third reading.
- From committee: Be ordered to second reading pursuant to Senate Rule 28.8.
- From committee: Do pass and re-refer to Com. on APPR. (Ayes 11. Noes 0.) (July 14). Re-referred to Com. on APPR.
- From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on B. P. & E.D.
- In committee: Set, first hearing. Hearing canceled at the request of author.
- In committee: Hearing postponed by committee.
- In committee: Hearing postponed by committee.
- From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on B. P. & E.D.
- Referred to Com. on B. P. & E.D.
- In Senate. Read first time. To Com. on RLS. for assignment.
- Read third time. Passed. Ordered to the Senate. (Ayes 77. Noes 0. Page 1737.)